Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Inhibition of STAT3 by 2-Methoxyestradiol suppresses M2 polarization and protumoral functions of macrophages in breast cancer
2ME2 inhibited texpression of several anti-inflammatory cytokines and growth factors.
»
09/10/24
Impact of interplay effects on spot scanning proton therapy with motion mitigation techniques for lung cancer: SFUD versus robustly optimized IMPT plans utilizing a four-dimensional dynamic dose simulation tool
In 5-phase plans, SFUD had higher deterioration rates for V-100% and HI than IMPT.
»
09/09/24
Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study
PFS and OS significantly longer when treatment response values for changes in CAR, PLR, and NLR below cutoff values.
»
09/09/24
Spatially fractionated GRID radiation potentiates immune-mediated tumor control
SFRT-GRID is successful with radiation-induced anti-tumor immunity
»
09/13/24
Exosomal transcript cargo and functional correlation with HNSCC patients' survival
SGK1 and MAD1L1 showed high expression.
»
09/13/24
Genetic polymorphism in untranslated regions of PRKCZ influences mRNA structure, stability and binding sites
Total of 24 variants present in 3-UTR and 25 variants present in t5-UTR most detrimental.
»
09/13/24
A triple hormone receptor ER, AR, and VDR signature is a robust prognosis predictor in breast cancer
THR signatures effectively predict both overall and progression-free survival .
»
09/13/24
Prophylactic para-aortic lymph node dissection in Colo-rectal cancer; pilot study
Study highlights value of prophylactic para-aortic lymph node dissection among colorectal cancer patients.
»
09/19/24
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients
Targeted induction therapies combining lenalidomide or ibrutinib with R-MPV feasible for first-line PCNSL.
»
09/19/24
Blood molybdenum level as a marker of cancer risk on BRCA1 carriers
Elevated blood molybdenum levels associated with increased risk of ovarian cancer on BRCA1 mutation carriers.
»
09/19/24
< Prev
Next >